Clinical Trial

Botswana Smoking and Abstinence Reinforcement Trial

Study acronym: BSMART
Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
Many people living with HIV in southern Africa, specifically Botswana use tobacco products. Using tobacco makes some of the effects of HIV worse and even causes excess deaths. The investigators plan to use an intervention called Screening, Brief Intervention and Referral to Treatment (SBIRT) to help people to quit smoking and also a drug called varenicline. Apart from helping people to stop smoking, the investigators will also test to see how task shifting can be used to help people stop smoking in a sustainable way. Finally, the investigators will estimate the cost of the intervention.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-01-11; most recent amendment 2026-01-07.
Status change: Not Yet Recruiting → Enrolling by Invitation 2023-07-28
Trial Details
NCT Number NCT05694637
Lead Sponsor University of Maryland, Baltimore
Collaborators: University of Maryland, Baltimore County, University of Maryland, College Park, University of Chicago
Conditions Smoking Cessation, Hiv
Enrollment 750 participants
Start Date 2023-07-25
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-09